CTPC

CTPC provides a curated collection of transcriptomic profiles from 1,840 samples across nine prostate cancer cell lines to support comparative and differential gene expression analyses and biomarker discovery.

Key Features:

• Dataset composition: Transcriptomic profiles from 1,840 samples derived from nine prostate cancer cell lines: LNCaP, LNCaP-95, LNCaP-abl, C4-2, VCaP, 22Rv1, PC3, DU145, and NCI-H660.
• Metadata annotation: Associated metadata links gene manipulation and drug treatment information to samples.
• Curated integration: Curated aggregation and integration of transcriptomic profiles to enable cross-sample comparisons.
• Analytical scope: Enables differential gene expression analyses and comparative analyses of gene expression patterns across cell lines.
• Data mining: Application of large-scale data mining techniques for analysis of transcriptomic patterns.

Scientific Applications:

• Differential expression analysis: Comparative identification of genes with altered expression across prostate cancer cell lines.
• Biomarker and target discovery: Identification of potential biomarkers and therapeutic targets specific to prostate cancer subtypes.
• Phenotype comparison: Comparative studies across a broad spectrum of prostate cancer phenotypes represented by the included cell lines.
• Perturbation and treatment studies: Linking gene manipulation and drug treatment metadata to expression changes for hypothesis testing.
• Translational research: Support for investigations aimed at informing targeted therapies and personalized medicine approaches.

Methodology:

Curated integration of transcriptomic profiles with associated metadata and application of large-scale data mining for comparative and differential gene expression analyses.